Leonid Kagan
Impact in
- Pharmaceutical Science top 0.5%
- Advanced Drug Delivery Systems
- Advancements in Transdermal Drug Delivery
- Drug Solubulity and Delivery Systems
- Dermatology top 5%
Papers in
-
- Drug Solubulity and Delivery Systems 5
- Advanced Drug Delivery Systems 5
- Pharmacology 11
- Antibiotics Pharmacokinetics and Efficacy 14
- Pharmacogenetics and Drug Metabolism 8
- Co-authors
- Donald E. MagerAmnon HoffmanJong Bong LeePavel GershkovichSathy V. Balu‐IyerJoel SegalMichael R. TurnerAjay K. Banga
- Journals
- Pharmaceutical Research (10 papers)Journal of Pharmaceutical Sciences (4 papers)Journal of Pharmaceutical and Biomedical Analysis (4 papers)Drug Metabolism and Disposition (4 papers)European Journal of Pharmaceutics and Biopharmaceutics (4 papers)
- Partner nations
- United StatesPolandIsrael
In The Last Decade
Leonid Kagan
75 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 129
- Pharmaceutical Science 416
- Dermatology 98
- Pharmacology 94
- Biomaterials 120
- Oncology 235
Countries citing papers authored by Leonid Kagan
This map shows the geographic impact of Leonid Kagan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leonid Kagan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leonid Kagan more than expected).
Fields of papers citing papers by Leonid Kagan
This network shows the impact of papers produced by Leonid Kagan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leonid Kagan. The network helps show where Leonid Kagan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Leonid Kagan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 2 | |
| 7 | 2024 | 0 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 1 | |
| 10 | 2023 | 0 | |
| 11 | 2023 | 0 | |
| 12 | 2023 | 9 | |
| 13 | 2022 | 12 | |
| 14 | 2022 | 23 | |
| 15 | 2022 | 5 | |
| 16 | 2020 | 6 | |
| 17 | Evaluation of treatment options for methicillin-resistant Staphylococcus aureus infections in the obese patient | 2019 | 0 |
| 18 | 2017 | 70 | |
| 19 | 2014 | 66 | |
| 20 | 2011 | 25 |
About Leonid Kagan
Leonid Kagan is a scholar working on Pharmaceutical Science, Pharmacology, Pharmacology, Oncology and Gastroenterology, having authored 87 papers that have together received 1.6k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (14 papers), Drug Transport and Resistance Mechanisms (13 papers), Anesthesia and Pain Management (9 papers), Monoclonal and Polyclonal Antibodies Research (9 papers), Pharmacogenetics and Drug Metabolism (8 papers), Drug Solubulity and Delivery Systems (5 papers), Advanced Drug Delivery Systems (5 papers) and Pharmacological Effects and Toxicity Studies (5 papers). The work is most often cited by research in Pharmaceutical Science (416 citations), Dermatology (98 citations), Pharmacology (94 citations), Biomaterials (120 citations) and Oncology (235 citations). Leonid Kagan has collaborated with scholars based in United States, Poland and Israel. Frequent co-authors include Donald E. Mager, Amnon Hoffman, Jong Bong Lee, Pavel Gershkovich, Sathy V. Balu‐Iyer, Joel Segal, Michael R. Turner, Ajay K. Banga, Maria Marlow and Akmal Hidayat Bin Sabri. Their work appears in journals such as Pharmaceutical Research, Journal of Pharmaceutical Sciences, Journal of Pharmaceutical and Biomedical Analysis, Drug Metabolism and Disposition and European Journal of Pharmaceutics and Biopharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.